Personal information

No personal information available

Activities

Collapse all

Employment (2)

South Valley University: Qena, EG

2017-08-11 to present | assistant teacher (pharmaceutics)
Employment
Source: Self-asserted source
hebatallah b mohamed

Assiut University: Assiut, child hospital, EG

2009-09 to 2017-07 | pharmacist
Employment
Source: Self-asserted source
hebatallah b mohamed

Education and qualifications (2)

Assiut University: Assiut, EG

2012 to present | master (pharmaceutics)
Education
Source: Self-asserted source
hebatallah b mohamed

Assiut University: Assiut, EG

2007 to present | B.Sc. pharmaceutical science
Education
Source: Self-asserted source
hebatallah b mohamed

Works (6)

A green chemistry approach for preparation of metronidazole-zinc (ІІ) complexes: In vitro characterization, antimicrobial activity and promising cytotoxicity

Journal of Drug Delivery Science and Technology
2024-05 | Journal article
DOI: 10.1016/j.jddst.2024.105616
Contributors: Hebatallah B. Mohamed; Aml I. Mekkawy; A.Z. Mahmoud; Dina Fathalla; Ehab A. Fouad
Source: check_circle
Crossref

Evaluation of Different Surface Coating Agents for Selenium Nanoparticles: Enhanced Anti-Inflammatory Activity and Drug Loading Capacity.

Drug design, development and therapy
2022-06-13 | Journal article
DOI: 10.2147/dddt.s360344
PMID: 35719212
PMC: PMC9205440
Contributors: Aml Imam Mekkawy; Fathy M; Mohamed HB
Source: Self-asserted source
hebatallah b mohamed

Current trends in pharmaceutical treatment of dry eye disease: A review.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
2022-05-11 | Journal article | Author
DOI: 10.1016/j.ejps.2022.106206
PMID: 35568107
Contributors: hebatallah b mohamed; Abd El-Hamid BN; Fathalla D; Fouad EA
Source: Self-asserted source
hebatallah b mohamed
grade
Preferred source (of 2)‎

Chitosan Nanoparticles for Meloxicam Ocular Delivery: Development, In Vitro Characterization, and In Vivo Evaluation in a Rabbit Eye Model.

Pharmaceutics
2022-04-20 | Journal article
DOI: 10.3390/pharmaceutics14050893
PMID: 35631479
PMC: PMC9148062
Contributors: Mohamed HB; Attia Shafie MA; Aml Imam Mekkawy
Source: Self-asserted source
hebatallah b mohamed

Nano-Structured Lipid Carrier-Based Oral Glutathione Formulation Mediates Renoprotection against Cyclophosphamide-Induced Nephrotoxicity, and Improves Oral Bioavailability of Glutathione Confirmed through RP-HPLC Micellar Liquid Chromatography.

Molecules (Basel, Switzerland)
2021-12-10 | Journal article
DOI: 10.3390/molecules26247491
PMID: 34946570
PMC: PMC8706828
Contributors: Ahmad AM; Hamdoon Mohammed; Tarek M. Faris; Hassan AS; Mohamed HB; El Dosoky MI; esam aboubakr
Source: Self-asserted source
hebatallah b mohamed

Niosomes: A Strategy toward Prevention of Clinically Significant Drug Incompatibilities.

Scientific reports
2017-07-24 | Journal article
DOI: 10.1038/s41598-017-06955-w
PMID: 28740102
PMC: PMC5524940
Contributors: Mohamed HB; El-Shanawany SM; Mostafa A. Hamad; Mahmoud Elsabahy
Source: Self-asserted source
hebatallah b mohamed
How many people are using ORCID?